DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20151344

Determination of hepatoprotective effect of Mussaenda erythrophylla in paracetamol induced hepatotoxicity

T. S. Rojin, Sukanya Shetty, Rajendra Holla

Abstract


Background: Hepatotoxicity may be defined as liver injury caused by drugs and chemicals. Drug-induced liver injury is a major reason for withdrawing drugs from a market by Food Drug Administration, and it is based on the fact that drug-induced liver injury is responsible for more than 50% of all cases of acute liver failure. Many studies revealed about the hepatotoxic potential of paracetamol. Hence, the present study has undertaken to evaluate the hepatoprotective effect of Mussaenda erythrophylla (ME) in paracetamol induced hepatotoxicity in Wistar albino rats.

Methods: The ethanolic extract ME studied for its hepatoprotective effect on paracetamol induced acute liver damage in Wistar albino rats. The degree of protection was measured using biochemical parameters such as serum glutamate oxalate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), total bilirubin (TBL), superoxide dismutase (SOD), glutathione (GSH) peroxidase (GPx), GSH, and ceruloplasmin levels.

Results: Paracetamol treated group had enhanced levels of SGPT, SGOT, TBL (p<0.001) and decreased levels of GSH, SOD, and GPx (p<0.001) when compared with control group. Treatment with silymarin and also 200 mg/kg of MEleaf extract had significantly (p<0.001) brought down the elevated levels of SGPT, SGOT, and TBL and an increase in the levels of GSH, SOD, (p<0.01), GPx and ceruloplasmin (p<0.001).

Conclusion: The results showed that ethanolic extract of ME leaf extract possesses significant hepatoprotective activity.


Keywords


Paracetamol, Mussaenda erythrophylla, Hepatotoxicity

Full Text:

PDF

References


Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279(15):1200.

Luper S. A review of plants used in the treatment of liver disease: part 1. Altern Med Rev. 1998;3(6):410-21.

Verma S, Singh SP. Current and future status of herbal medicines. Vet World. 2008;1:347-50.

Chandira M, Jayakar B. Formulation and evaluation of herbal tablets containing Ipomoea digitata Linn. extract. Int J Pharm Sci Rev Res. 2010;3:101-10.

Jaya Raju N, Ganga Rao B. Anthelmintic activities of antigonon leptopus hook and Mussaenda erythrophylla. Int J Pharm Pharm Sci. 2011;3:2011.

Venkatesh K, Rao U, Kiranmayi GV, Narasimha Naik R, Mukharjee NS, Vinay VN, et al. Phytochemical screening and evaluation of diuretic activity of ethanolic and chloroform extracts of Mussaenda erythrophylla in rats. IJBPR. 2013;4:8-10.

Eswaraiah MC, Satyanarayana T. Hepatoprotective activity of extracts from stem of M. erythrophylla against carbon tetrachloride - induced toxicity in rats. JPRHC. 2009;2:23-31.

Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug induced hepatic injuries: a French population based study. Hepatology. 2002;36:451.

LeBlanc GA. Hepatic vectorial transport of xenobiotics. Chem Biol Interact. 1994;90(2):101-20.

Mitchell JR, Thorgeirsson SS, Potter WZ, Jollow DJ, Keiser H. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther. 1974;16(4):676-84.

Holt CD, Arriola E. Adverse effects of drugs on the liver. In: Koda- Kimble MA, Yong LY, Kradjan WA, Guglielmo BJ, editors. Applied Therapeutics the Clinical use of Drugs. 8th Edition. United States of America: Lippincott Williams and Wilkins; 2005: 30-4.

Losser MR, Payen D. Mechanisms of liver damage. Semin Liver Dis. 1996;16(4):357-67.

Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci. 2002;65(2):166-76.

Murugesh KS, Yeligar VC, Maiti BC, Maity TM. Hepato protective and antioxidant role of Berberis tinctoria Lesch leaves on paracetamol induced hepatic damage in rats. Int J Pharm Technol. 2005;4:64-9.

Martin SJ, Vedi M, Lavinya BU, Benny B, Agnes Selina K, Anne Sahithi ST, et al. Protective role of food supplement Spirulina fusiformis in chemical induced hepatotoxicity: a bromobenzene model in rats. Int J Pharmacol Res. 2014;4(1):4-9.

Iskusnykh IY, Popova TN, Agarkov AA, Pinheiro de Carvalho MA, Rjevskiy SG. Expression of glutathione peroxidase and glutathione reductase and level of free radical processes under toxic hepatitis in rats. J Toxicol. 2013;2013:Article ID 870628.

Bagchi K, Puri S. Free radicals and antioxidants in health and disease. IJCRR. 1998;4(19):350-60.

Wang GS, Han ZW. The protective action of glycyrrhiza flavonoids against carbon tetrachloride hepatotoxicity in mice. Yao Xue Xue Bao. 1993;28:572-6.

Vargas-Mendoza N, Madrigal-Santillán E, Morales-González A, Esquivel-Soto J, Esquivel-Chirino C, González-Rubio MG, et al. Hepatoprotective effect of silymarin. World J Hepatol. 2014;6:144-9.

Rasool M, Iqbal J, Malik A, Ramzan HS, Qureshi MS, Asif M, et al. Hepatoprotective effects of Silybum marianum (Silymarin) and Glycyrrhiza glabra (Glycyrrhizin) in combination: a possible synergy. Evid Based Complement Alternat Med. 2014;2014:641597.

El-Banna H, Ramadan S, Shalaby M, Afif N. Hepatoprotective and antioxidant effects of Silybum marianum plant in rats. IJAVMS. 2011;5(6):541-7.

Favari L, Pérez-Alvarez V. Comparative effects of colchicine and silymarin on CCl4-chronic liver damage in rats. Arch Med Res. 1997;28:11-7.

Faulstich H, Jahn W, Wieland T. Silybin inhibition of amatoxin uptake in the perfused rat liver. Arzneimittelforschung. 1980;30:452-4.

Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 2006;124:491-504.

Eswaraiah MC, Elumalai A. Isolation of phytoconstituents from the stems of Mussaenda erythrophylla. Pharm Sin. 2011;2:132-42.